Printer Friendly

CIBA-GEIGY CORP AND CIBA-GEIGY CANADA LTD. COMPLETE PURCHASE OF FISONS' NORTH AMERICAN CONSUMER HEALTHCARE BUSINESS

 SUMMIT, N.J., Jan. 7 /PRNewswire/ -- Ciba-Geigy Corp. and Ciba-Geigy Canada Ltd. today announced the unconditional completion of the purchase of Fisons' North American consumer healthcare business reported on Nov. 25, 1992.
 Following is Ciba's Nov. 26 press release:
 CIBA ACQUIRES FISONS' NORTH AMERICAN OTC BUSINESS
 Ciba Consumer Pharmaceuticals (CCP), a division of the American Ciba-Geigy Corporation, and Ciba-Geigy Canada Ltd. (CGC) have reached an agreement with Fisons plc, lpswich (UK), to purchase Fisons' North American OTC business. The purchase price for the entire transaction consists of US$115 million for the US and Canada brand portfolio plus, approximately US$25 million for the current assets in these markets.
 Fisons' OTC business will significantly strengthen CCP's and CGC's existing OTC market presence. The brand portfolio acquired includes such popular brands as Desenex(R), Cruex(R) (antifungal medications), the Allerest(R) line of allergy relief products, Myoflex(R) (topical analgesic) and several other skin care products such as Caldesene(R), Caldecort(R), Americaine(R) and Delsym(R) in Canada.
 CCP markets many other popular over the counter medications such as Doan's(R) (backache remedy), Dulcolax(R) and Fiberall(R) (laxatives), Acutrim(R) (appetite suppressants), Sunkist(R) (vitamin) and Slow Fe(R) (iron preparation) and Transderm Scop(R), (a transdermal (patch) travel sickness product containing 15 mg of scopalomine, which is available on prescription only).
 The acquisition forms part of Ciba's strategy of attaining and expanding a leading position in key OTC markets.
 -0- 1/7/93
 /CONTACT: Rich Salem, Pharmaceuticals Division of Ciba-Geigy Corporation, 908-277-7158/


CO: Ciba-Geigy Corp.; Ciba-Geigy Canada Ltd.; Fisons ST: New Jersey IN: MTC SU: TNM

WB-KW -- NY078 -- 2721 01/07/93 14:01 EST
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Jan 7, 1993
Words:277
Previous Article:RESEARCH REPORT ON LEADING SPANISH HYPERMARKET CHAIN
Next Article:WEST PENN POWER $322 MILLION SHELF DEBT RATED 'A+' BY FITCH -- FITCH FINANCIAL WIRE --
Topics:


Related Articles
THE CIBA-GEIGY HIGH SCHOOL CHEMISTRY INSTITUTE; SUMMER SCHOOL WITH A SCIENTIFIC TWIST
CIBA-GEIGY REPORTS 1992 MIDYEAR SALES RESULTS
CIBA-GEIGY TURNS CRITICS INTO ADVISORS, SAYS ZIEGLER
CIBA-GEIGY REPORTS SALES FOR THE FIRST THREE QUARTER OF 1992
CIBA-GEIGY REPORTS THIRD QUARTER SALES
CIBA-GEIGY REPORTS THIRD QUARTER SALES
CIBA HONORED FOR COMMITMENT TO EDUCATION
CIBA ANNOUNCES 1992 RESULTS
CIBA ANNOUNCES FIRST QUARTER SALES RESULTS
SANDOZ-CIBA GEIGY MERGER WOULD CREATE EIGHTH-LARGEST PHARMACEUTICAL FIRM IN U.S.

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters